Cara Therapeutics
CARA
₹30.50
Share price
-6.08%
Change (1 day)
-59.20%
Change (1 year)
Categories
Cara Therapeutics (CARA) - Total liabilities
Total liabilities on the balance sheet as of September 2024 : ₹4.34 Billion
According to Cara Therapeutics 's latest financial reports the company's total liabilities are ₹4.34 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Cara Therapeutics - Total liabilities on balance sheet (from 2012 to 2024)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | ₹5.72 B | 194.88% |
| 2022-12-31 | ₹1.94 B | 33.51% |
| 2021-12-31 | ₹1.45 B | -10.27% |
| 2020-12-31 | ₹1.62 B | -50.87% |
| 2019-12-31 | ₹3.29 B | -17.53% |
| 2018-12-31 | ₹3.99 B | 512.59% |
| 2017-12-31 | ₹0.65 B | -26.68% |
| 2016-12-31 | ₹0.89 B | 128.92% |
| 2015-12-31 | ₹0.38 B | 43.66% |
| 2014-12-31 | ₹0.27 B | -33.32% |
| 2013-12-31 | ₹0.40 B | 139.36% |
| 2012-12-31 | ₹0.16 B | -30% |
| 2011-12-31 | ₹0.24 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 | ₹3.65 B | -16.05% | 🇺🇸 USA |
 | ₹0.54 B | -87.57% | 🇺🇸 USA |
 | ₹10.729 T | 246,628.70% | 🇺🇸 USA |
 | ₹9.330 T | 214,458.89% | 🇺🇸 USA |
 | ₹22.96 B | 428.12% | 🇺🇸 USA |